Amarin Corp Plcuk (AMRN) Other financing activities (2010 - 2025)
Amarin Corp Plc\Uk (AMRN) posted quarterly Other financing activities of $83000.0 for Q4 2025, up 8400.0% year-over-year from $976.47 in Q4 2024, and up 8400.0% quarter-over-quarter from -$1000.0 in Q4 2024.
Amarin Corp Plcuk (AMRN) Other financing activities (2010 - 2025) Analysis & Trends
Amarin Corp Plc\Uk (AMRN) has reported Other financing activities for 16 consecutive years, with $83000.0 the latest figure, recorded in Q4 2025.
- In Q4 2025, Other financing activities rose 8400.0% year-over-year to $83000.0; the TTM figure through Dec 2025 stood at $82000.0 (down 32.23% YoY), while the FY2025 annual figure was $140000.0, up 15.7% from the prior year.
- Other financing activities advanced to $83000.0 in Q4 2025 per AMRN's latest filing, from -$1000.0 in the prior quarter.
- Across five years, Other financing activities topped out at $2.1 million in Q1 2021 and bottomed at -$1000.0 in Q4 2024.
- Historically, Other financing activities has averaged $351875.0 across 5 years, with a median of $52500.0 in 2021.
- Annual changes were most pronounced in 2024 — Other financing activities plunged 105.0% — and 2025, when it surged 8400.0%.
- Amarin Corp Plc\Uk's Other financing activities stood at $306000.0 in 2021, then surged by 78.43% to $546000.0 in 2022, then plunged by 96.34% to $20000.0 in 2023, then plunged by 105.0% to -$1000.0 in 2024, then soared by 8400.0% to $83000.0 in 2025.
- Business Quant data shows AMRN's Other financing activities at $83000.0 in Q4 2025, -$1000.0 in Q4 2024, and $112000.0 in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn |
| 10 | Amarin Corp Plcuk | 5.86 Bn | 5.54 Bn | 14.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 83,000.00 |
| Dec 31, 2025 | 83,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Dec 31, 2024 | -1,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Jun 30, 2024 | 112,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Mar 31, 2024 | 10,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Dec 31, 2023 | 20,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Sep 30, 2023 | 2,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Jun 30, 2023 | 7,000.00 |
| Mar 31, 2023 | 1.87 Mn |
| Mar 31, 2023 | 1.87 Mn |
| Dec 31, 2022 | 546,000.00 |
| Dec 31, 2022 | 546,000.00 |
| Sep 30, 2022 | 10,000.00 |
| Sep 30, 2022 | 10,000.00 |